Tirzepatide and Constipation: What Helps and When to Get Care

Constipation is a reported side effect of tirzepatide. Find the warning signs, what to track, and when to contact your clinician or pharmacist.

Majesta Health Editorial TeamReviewed by Ksenia Petrushkina, PA-C, co-founder
Published Updated 5 min read

Can tirzepatide cause constipation?

Yes. The prescribing information for Zepbound, a tirzepatide injection, lists constipation, including hard stools. NIDDK includes fewer than three bowel movements a week among possible signs. Stool hardness, straining and a feeling of incomplete emptying also matter. A change in how often you go is one part of the picture. With constipation, get medical help right away if you also have rectal bleeding, blood in your stool, severe or constant abdominal pain, vomiting or cannot pass gas. Zepbound prescribing information, section 6, NIDDK constipation symptoms and urgent signs.

Constipation on tirzepatide: what to do next

What you noticeWhat to do
Mild hard stools or straining, without other warning signsNote the change, what you have been able to eat and drink, and any other medicines you take. Ask a clinician or pharmacist which self-care options fit your history.
Symptoms keep coming back, are getting worse, or continue despite simple measuresContact the prescribing team. Tell them if symptoms began after starting or changing treatment and whether eating or drinking has become difficult.
Constipation with rectal bleeding, blood in stool, severe or constant abdominal pain, vomiting, fever, inability to pass gas, lower back pain or unexplained weight lossGet medical help right away. Share which medicine you take and when you last used it.

The symptom descriptions and escalation signs come from NIDDK guidance. The tirzepatide label also asks patients to contact a healthcare provider for severe or persistent gastrointestinal symptoms. Zepbound prescribing information, sections 5.2 and 17.

What the studies and label can tell you

In two pooled Zepbound weight-management trials in adults, constipation was reported by 17% of people assigned to 5 mg, 14% assigned to 10 mg, 11% assigned to 15 mg and 5% assigned to placebo. The category included hard stools. These are study-group rates for Zepbound injections. They cannot tell you how long symptoms will last or estimate the rate for a different product or a compounded preparation. Zepbound prescribing information, section 6.1, Table 1. The Zepbound side effects guide covers the broader safety profile.

Tirzepatide delays gastric emptying. The label documents that effect separately from the reports of constipation. It does not establish a usual duration for constipation. Watch for changes in stool hardness, straining and how easily you pass gas, alongside how often you go. Zepbound prescribing information, sections 6 and 12.2, NIDDK symptom list.

The Zepbound label includes reports of intestinal obstruction and severe constipation with fecal impaction after approval. These are voluntary reports. The label explains that their frequency and a causal relationship to tirzepatide cannot always be established reliably. Use the warning signs above to decide when you need help. Zepbound prescribing information, section 6.2.

What you can discuss with your clinician or pharmacist

Tell your care team promptly if ongoing nausea, vomiting or diarrhea makes it difficult to stay hydrated. The label warns about reported kidney injury related to dehydration. If you also take insulin or a medicine such as a sulfonylurea, tell your clinician if you are eating much less. Using either with tirzepatide can increase the risk of low blood sugar. For questions about eating and drinking when you feel sick, see tirzepatide and nausea. Zepbound prescribing information, sections 5.3, 5.7 and 17.

If fullness or nausea affects what you can eat, read meal ideas for lower appetite. That guide covers food choices and when to seek help. If your prescription is semaglutide, the semaglutide and constipation guide covers that medicine separately.

Bring a brief symptom note to your appointment

  1. Write the product and presentation on your label and when you last used it. See how to read a prescription label.
  2. Note when stools changed, how hard they are to pass, and whether you have pain, nausea, vomiting or trouble drinking.
  3. List any recent changes in medicines, supplements or eating patterns. Ask how to handle symptoms before making changes to your prescription.

If you have a procedure with general anesthesia or deep sedation coming up, tell the treatment team that you take tirzepatide. They can give you instructions for your own procedure. Zepbound prescribing information, sections 5.9 and 17.

Frequently Asked Questions

Does tirzepatide cause constipation?

Constipation, including hard stools, is reported in the prescribing information for Zepbound, a tirzepatide injection. The rates are specific to the product and trial groups studied.

How long does tirzepatide constipation last?

The prescribing information does not establish a typical duration for constipation. Contact the prescribing team if symptoms persist, recur, or worsen.

When should I worry about constipation on tirzepatide?

Get medical help right away if constipation comes with rectal bleeding, blood in stool, severe or constant abdominal pain, vomiting, fever, inability to pass gas, lower back pain, or unexplained weight loss.

Can I take a laxative or a fiber supplement with tirzepatide?

Ask your pharmacist or clinician which options fit your symptoms, medicines and medical history. Get assessed promptly if you have warning signs.

Should I stop tirzepatide because of constipation?

Tell the prescribing clinician about your symptoms before changing your treatment plan. Get medical help right away for warning signs, and tell the treating team what you take.

Should I tell the surgery or procedure team I take tirzepatide?

Yes. Tell the treating team if a procedure involves general anesthesia or deep sedation. Ask them for specific instructions before the procedure.

Sources

This article is based on the following primary sources. Links open the original documents.

  1. 1.Zepbound prescribing information, sections 5, 6, 7.2, 12.2 and 17 · DailyMed, U.S. National Library of Medicine (Eli Lilly prescribing information) · accessed
  2. 2.NIDDK constipation symptoms and urgent signs · National Institute of Diabetes and Digestive and Kidney Diseases · accessed
  3. 3.NIDDK fiber and fluids guidance · National Institute of Diabetes and Digestive and Kidney Diseases · accessed
  4. 4.NIDDK constipation treatment · National Institute of Diabetes and Digestive and Kidney Diseases · accessed
Editorial review

Majesta Health Editorial Team

Editorial Team

Reviewed by Ksenia Petrushkina, PA-C, co-founder

Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. Clinical articles written by the Editorial Team name Ksenia Petrushkina, PA-C, a certified physician assistant and co-founder of Majesta Health, as reviewer. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.

How Majesta articles are prepared
  • Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
  • Documented compliance review against FDA, FTC and LegitScript requirements before publication
  • External sources, where an article cites them, are listed at the end of that article with links to the original documents
  • Compounded medications are described as not FDA-approved as final products on every page that mentions them
Have a question for our medical team? See our full clinical team page or contact support.

Ready to Join Early Access?

Join the early access list and we will email you when enrollment opens.

Start Your Assessment